Cleveland Magazine’s Post

PKD is a form of chronic kidney disease (CKD) that reduces kidney function and may lead to kidney failure. KD is a form of chronic kidney disease (CKD) that reduces kidney function and may lead to kidney failure. PKD also can cause other complications, or problems, such as high blood pressure, cysts in the liver, and problems with blood vessels in your brain and heart. #PolycysticKidneyDisease #kidneyawareness #moleculargenetictesting

Did you know October is #NationalLiverAwarenessMonth? NASH is a severe form of non-alcoholic fatty liver disease (NAFLD) that affects up to 20 million people in the United States, and up to 5% of the global population, and for which there is currently no approved therapy in the United States or Europe. American Liver Foundation's Think Liver Think Life national public health campaign aims to ensure every American understands their risk for liver disease, receives the appropriate diagnostic testing and care coordination and feels well-informed and supported throughout their liver journey. Learn more: https://lnkd.in/eyJp666K

Have you considered giving up or reducing your alcohol intake as a New Year’s resolution? Excessive alcohol intake is a risk factor for high blood pressure, heart disease, stroke, liver disease, digestive problems, and cancer of the breast, mouth, throat, esophagus, voice box, liver, colon, and rectum. It also weakens the immune system, increasing your chances of getting sick. Learn more about the benefits of Dry January with Dr. Kerry Scott: https://lnkd.in/gzya6j7T

MRE has high diagnostic performance for staging liver fibrosis, but interpretation must include consideration of coexisting conditions such as inflammation and hepatic venous congestion. https://lnkd.in/eWDgrEzN

Check out this short clip!

Have you heard of the ‘gut-liver axis’? Truth be told, our liver and gut are highly connected and one system can impact the other. So if you have Irritable Bowel Syndrome (IBS) and have also been told you may have a fatty liver or diagnosed with Non-Alcoholic Fatty Liver Disease (NAFLD), then this might not be simply a coincidence! This article explains how to eat if you have both conditions. https://lnkd.in/edAMSS3s

Discover the stages of liver health with our insightful breakdown. Join the fight against fatty liver disease – Enroll in our clinical trial today! Click here to see if you qualify: https://lnkd.in/dbFpAYaA You may qualify to receive up to $2,000-$3,000 compensation upon enrollment in one of our Clinical Trials. #bradenton #florida #clinicalresearch #clinicaltrials #liverdiseasetreatment #liverdiseaseresearch #liverfunction #livercare #liverdiseaseawarenessmonth #liverdiseaseawarenessweek #liverdiseaseawarenessday #liverawareness #liverwellness #liverhealthawareness #liverhealthmatters #liverhealthcheck #liverhealthawarenessmonth #liverhealthawarenessweek #liverhealthawarenessday #liverhealthawarenesscampaign #hepatichealth #takecareofyourheatlh #healthylife #healthycheckup #checkyourself #medicaltreatmeant

The terminology for liver conditions is evolving! Non-Alcoholic Fatty Liver Disease (NAFLD) is now reclassified as Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD). This new term better reflects the metabolic factors driving the condition, leading to improved diagnosis and treatment Read More: https://lnkd.in/gTi_Ahje. Stay informed and proactive about your liver health with insights from Dr. Karthik Mathivanan at Liverindia.in. #LiverHealth #MASLD #MetabolicHealth #metabolichealth #metabolichealth

Thanks for sharing this great article Kate. A few things jump out: 1) There is still a lot of misunderstanding around liver disease, and it's promising to see conditions like metabolic liver disease attracting more attention in the general media. This article explains the issues perfectly! A huge percentage of people with liver disease do not drink alcohol. 2) There is a danger that when we talk about 1 in 3 people having liver disease, policymakers become paralyzed by the scale of the issue. It's important to note that whilst, according to some reports, 30% of us have some degree of excess fat in our livers, not all will progress to cirrhosis, cancer or liver failure. 3) This is an urgent issue that needs addressing now. Liver-related mortality rates are trending in the wrong direction, unlike most other diseases. More people are developing steatotic (fatty) liver disease, and as comorbidities (like type 2 diabetes) become more common, people are getting sicker, quicker. Add to this the advent of new treatments including Madrigal Pharmaceuticals Resmetirom. We think that one of the keys to getting ahead of this Tsunami* (*credit Roger Green) lies in intelligence gathering and deployment. If you can use real-world data to recognize the patterns in those cases that do progress from simple steatosis to advanced disease, we're no longer talking about treating 1 in 3. We can then use a case-finding approach, and historic blood tests to find these high-risk people BEFORE they progress. “The life depends on the liver”. We couldn't have said it better ourselves. #liverdisease #publichealth #FattyLiver p.s. Thanks to New Scientist for yet another great article.

When the human body creates its on natural bypasses. Coronary collaterals: Right coronary artery to the Left anterior descending artery. (Image shown) The RCA even as its suffering with a severe, long segment disease it helps out-of-the-way, with a long arm of support to the entire LAD. Collateral vessels, can develop in the heart as an adaptation to ischemia, and provide an alternative source of blood supply to myocardium jeopardized by occlusive coronary artery disease, and they can help to preserve myocardial function in the setting of a chronic total coronary occlusion.